EP Biocomposites Limited

BSE:543595 Stock Report

Market Cap: ₹338.5m

EP Biocomposites Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure3yrs
Board average tenure4.9yrs

Recent management updates

Recent updates


CEO

EP Biocomposites has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Rajkumar Kamat
Founder5yrs₹1.80m4.3%
₹ 14.6m
Nilam Kadkade
Chief Financial Officer4.8yrs₹498.00kno data
Deepa Agarwal
Company Secretary & Compliance Officerless than a year₹25.00kno data
Melvin Antao
Asst Manager of Sales4.3yrsno datano data
Shreyas Nadkarni
Executive Director3yrsno datano data
Hemant Kalangutkar
Chief of FRP Division & Head of Architectural Divisionno datano data0.11%
₹ 372.4k
Dattaram Chimulkar
Chief of Bio Division & Head of Bio Digester Divisionno datano data0.11%
₹ 372.4k
Dalesh Kossambe
DGM & Head of Aqua Division2yrsno datano data
Bhaskar Rege
Senior Sales Personno datano datano data

3.0yrs

Average Tenure

48yo

Average Age

Experienced Management: 543595's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Rajkumar Kamat
Founder5yrs₹1.80m4.3%
₹ 14.6m
Shreyas Nadkarni
Executive Director3yrsno datano data
Nitin Kunkolienker
Non-Executive Independent Director4.8yrs₹8.00kno data
Leena Kamat
Non-Executive Director5yrsno data64.93%
₹ 219.8m
Dinesh Shenoy
Non-Executive Independent Director4.9yrs₹8.00kno data

4.9yrs

Average Tenure

59yo

Average Age

Experienced Board: 543595's board of directors are considered experienced (4.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 23:20
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EP Biocomposites Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution